PACB

Pacific Biosc

1.181

+0.031+2.70%

Opening11:10 08/17 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE1.260/1.270

TODAY RANGE1.220-1.320

VOL4.76M

MARKET CAP382.32M

52 WEEK RANGE1.070-2.730

AVG VOL (3M)6.49M

% TURNOVER1.53%

TURNOVER--

P/E (TTM)-2.8532

% RANGE7.48%

EPS(TTM)-0.4311

P/E(FORWARD)-2.7955

P/B-11.5061

BVPS-0.1069

DIVIDEND--

P/S2.321

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP347.88M

SHARES OUTSTANDING310.83M

NEXT EARNINGS11/03-11/09

FREE FLOAT282.83M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

TipRanks·3d ago
Pacific Biosciences: Buy Rating Reaffirmed with Unchanged $3 Price Target Amid Temporary Headwinds and Long-Term Growth Drivers
NASDAQ·4d ago
PacBio Cuts Outlook as SPRQ-Nx Transition Slows, Targets 2028 Cash-Flow Positivity
TipRanks·08/07 00:20
Pacific Biosciences Earnings Call: Growth Amid Headwinds
NASDAQ·08/06 17:04
PacBio Q2 Earnings Meet Estimates, Revenues Miss, 2026 Sales View Cut
TipRanks·08/06 11:11
Canaccord Genuity Sticks to Their Buy Rating for Pacific Biosciences (PACB)
TipRanks·08/06 09:50
Analysts Offer Insights on Healthcare Companies: Biodesix (BDSX), Pacific Biosciences (PACB) and Odyssey Therapeutics, Inc. (ODTX)
Seeking Alpha·08/06 05:41
Pacific Biosciences: It's Only Getting Worse
TipRanks·08/05 23:35
PacBio CEO Christian Henry steps down, Mark Van Oene succeeds
Dow Jones·08/05 22:20
Pacific Biosciences of California Appoints New CEO, Plans to Cut 8% of Workforce
TipRanks·08/05 21:31
PacBio reports Q2 EPS (14c), consensus (13c)
TipRanks·08/05 21:31
PacBio cuts FY26 revenue view to $155M-$165M from $165M-$175M
TipRanks·08/05 21:14
PacBio Restructures Operations and Appoints New CEO
Seeking Alpha·08/05 20:47
PacBio appoints COO as new CEO
Dow Jones·08/05 20:38
*PacBio: Appoints Mark Van Oene as Pres and CEO >PACB
Seeking Alpha·08/05 20:16
Pacific Biosciences of California Non-GAAP EPS of -$0.14 misses by $0.01, revenue of $39M misses by $1.58M

Same Industry

Name/Symbol

Change%

Price

Pacific Biosc

PACB

+2.70%

1.181

TMO

Waters

WAT

-1.07%

407.74

DHR

Fulgent Genetics

FLGT

-0.48%

18.57

Resmed

RMD

-0.18%

219.98

CHKP

Agilent Technologies Inc

+0.21%

148.84

ABMD

Ge Healthcare Technologies Inc

GEHC

-0.14%

73.69

ISRG

Veeva Sys Inc

VEEV

-2.22%

238.34

Revvity Inc

RVTY

-0.56%

116.84

Edwards Lifesciences Corp

-1.04%

91.60

INMD

ATHN

Bruker Corp

BRKR

-1.40%

56.86

VARIAN MEDICAL

VAR

0.00%

0.0000

ITGR

HOLX

Quidel

QDEL

+1.96%

14.58

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.